Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Osada

Showing results (11-20 of 476) with videos related to

Pageof 48
Sort By:
Current Drug Targets|October 4, 2012
Phosphorylation-dependent protein-protein interaction modules as potential molecular targets for cancer therapyNobumoto Watanabe, Hiroyuki Osada
Current Pharmaceutical Design|August 28, 2012
High-throughput screening identifies small molecule inhibitors of molecular chaperonesYasumitsu Kondoh, Hiroyuki Osada
Annals of the New York Academy of Sciences|March 23, 2004
Molecular interaction between cyclophilin D and adenine nucleotide translocase in cytochrome c release: does it determine whether cytochrome c release is dependent on permeability transition or not?Kiyotaka Machida, Hiroyuki Osada
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Development of novel angiogenesis inhibitors targeting VEGF (vascular endothelial growth factor) for cancer chemotherapy]Hideaki Kakeya, Hiroyuki Osada
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Cytoskeletal system]Makoto Kawatani, Hiroyuki Osada
Methods in Molecular Biology (Clifton, N.J.)|December 7, 2018
Proteomic Profiling for Target Identification of Biologically Active Small Molecules Using 2D DIGEMakoto Muroi, Hiroyuki Osada
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Cell cycle]Nobumoto Watanabe, Hiroyuki Osada
Bioorganic & Medicinal Chemistry|March 28, 2016
Small molecules that target phosphorylation dependent protein-protein interactionNobumoto Watanabe, Hiroyuki Osada
Vitamins and Hormones|March 17, 2025
Small-molecule inhibitors of glucose transportersMakoto Kawatani, Hiroyuki Osada
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Novel angiogenesis inhibitors for molecular target therapy of cancer]Hiroyuki Osada, Hideaki Kakeya
Pageof 48

Showing results (11-20 of 476) with videos related to

Sort By:
Pageof 48
Current Drug Targets|October 4, 2012
Phosphorylation-dependent protein-protein interaction modules as potential molecular targets for cancer therapyNobumoto Watanabe, Hiroyuki Osada
Current Pharmaceutical Design|August 28, 2012
High-throughput screening identifies small molecule inhibitors of molecular chaperonesYasumitsu Kondoh, Hiroyuki Osada
Annals of the New York Academy of Sciences|March 23, 2004
Molecular interaction between cyclophilin D and adenine nucleotide translocase in cytochrome c release: does it determine whether cytochrome c release is dependent on permeability transition or not?Kiyotaka Machida, Hiroyuki Osada
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Development of novel angiogenesis inhibitors targeting VEGF (vascular endothelial growth factor) for cancer chemotherapy]Hideaki Kakeya, Hiroyuki Osada
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Cytoskeletal system]Makoto Kawatani, Hiroyuki Osada
Methods in Molecular Biology (Clifton, N.J.)|December 7, 2018
Proteomic Profiling for Target Identification of Biologically Active Small Molecules Using 2D DIGEMakoto Muroi, Hiroyuki Osada
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Cell cycle]Nobumoto Watanabe, Hiroyuki Osada
Bioorganic & Medicinal Chemistry|March 28, 2016
Small molecules that target phosphorylation dependent protein-protein interactionNobumoto Watanabe, Hiroyuki Osada
Vitamins and Hormones|March 17, 2025
Small-molecule inhibitors of glucose transportersMakoto Kawatani, Hiroyuki Osada
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Novel angiogenesis inhibitors for molecular target therapy of cancer]Hiroyuki Osada, Hideaki Kakeya
Pageof 48